11-66070551-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_018026.4(PACS1):​c.65G>A​(p.Gly22Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000283 in 1,413,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 7.9e-7 ( 0 hom. )

Consequence

PACS1
NM_018026.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.73
Variant links:
Genes affected
PACS1 (HGNC:30032): (phosphofurin acidic cluster sorting protein 1) This gene encodes a protein with a putative role in the localization of trans-Golgi network (TGN) membrane proteins. Mouse and rat homologs have been identified and studies of the homologous rat protein indicate a role in directing TGN localization of furin by binding to the protease's phosphorylated cytosolic domain. In addition, the human protein plays a role in HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the TGN, thereby enabling HIV-1 to escape immune surveillance. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), PACS1. . Gene score misZ 3.71 (greater than the threshold 3.09). Trascript score misZ 3.8723 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, autosomal dominant 40, Schuurs-Hoeijmakers syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.13412979).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PACS1NM_018026.4 linkuse as main transcriptc.65G>A p.Gly22Glu missense_variant 1/24 ENST00000320580.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PACS1ENST00000320580.9 linkuse as main transcriptc.65G>A p.Gly22Glu missense_variant 1/241 NM_018026.4 P2Q6VY07-1
PACS1ENST00000527224.1 linkuse as main transcriptn.189G>A non_coding_transcript_exon_variant 1/72

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151708
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD4 exome
AF:
7.92e-7
AC:
1
AN:
1262102
Hom.:
0
Cov.:
31
AF XY:
0.00000161
AC XY:
1
AN XY:
620514
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000158
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151708
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74088
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000478
Bravo
AF:
0.0000302

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Schuurs-Hoeijmakers syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJan 22, 2021The c.65G>A (p.Gly22Glu) variant identified in the PACS1 gene substitutes a moderately conserved Glycine for Glutamic Acid at amino acid 22/964 (exon 1/24). This variant is found with low frequency in gnomAD (3 heterozygotes, 0 homozygotes; allele frequency: 1.98e-5) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms do not agree on the function of this variant, as it is predicted both Damaging (SIFT; score:0.00) and Benign (REVEL; 0.03099) to the function of the canonical transcript. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature. Given the lack of compelling evidence for its pathogenicity, the c.65G>A (p.Gly22Glu) variant identified in the PACS1 gene is reported as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.032
T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.56
T
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N
MutationTaster
Benign
0.75
N
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.32
N
REVEL
Benign
0.031
Sift
Pathogenic
0.0
D
Sift4G
Benign
1.0
T
Polyphen
0.036
B
Vest4
0.14
MutPred
0.33
Gain of solvent accessibility (P = 0.0145);
MVP
0.16
MPC
1.5
ClinPred
0.49
T
GERP RS
3.5
Varity_R
0.26
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1857288713; hg19: chr11-65838022; API